Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pathology
Volume 2015, Article ID 949670, 3 pages
http://dx.doi.org/10.1155/2015/949670
Case Report

Leishmaniasis Panamensis Masquerading as Myiasis and Sporotrichosis: A Clinical Pitfall

1Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA
2Division of General Pediatrics, Children’s Hospital Los Angeles, Los Angeles, CA 90027, USA

Received 21 June 2015; Accepted 18 August 2015

Academic Editor: Sei-ichiro Motegi

Copyright © 2015 Peter G. Pavlidakey et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Control of the Leishmaniases, World Health Organization, Geneva, Switzerland, 2010.
  2. R. E. Varela M, D. Lorena Muñoz, S. M. Robledo et al., “Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug,” Experimental Parasitology, vol. 122, no. 2, pp. 134–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Blum, P. Desjeux, E. Schwartz, B. Beck, and C. Hatz, “Treatment of cutaneous leishmaniasis among travellers,” Journal of Antimicrobial Chemotherapy, vol. 53, no. 2, pp. 158–166, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. Center of Disease Control, Diagnosis of Leishmaniasis, CDC, Atlanta, Ga, USA, 2013.
  5. A. J. Magill, “Cutaneous leishmaniasis in the returning traveler,” Infectious Disease Clinics of North America, vol. 19, no. 1, pp. 241–266, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Blum, P. Buffet, L. Visser et al., “LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travelers, 2014,” Journal of Travel Medicine, vol. 21, no. 2, pp. 116–129, 2014. View at Publisher · View at Google Scholar · View at Scopus